Full Length Research Paper
References
|
Arovita P, Teramo K, Hiilesmaa V, Kekomaki R (2005). Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion 45(4):613-21
Crossref |
||||
|
|
||||
|
Bhatia M, Bonnet D, Kapp U, Wang J, Murdoch B, Dick J (1997). Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186: 619-624.
Crossref |
||||
|
|
||||
|
Bhatia M, Bonnet D, Murdoch B, Gan O, Dick J (1998). A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 4:1038-1045.
Crossref |
||||
|
|
||||
|
Bhatia M, Wang J, Kapp U, Bonnet D, Dick J (1997). Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U S A. 94:5320-5325.
Crossref |
||||
|
|
||||
|
Cheung A, Wan T, Leung J, Chan L, Huang H, Kwong YL, Liang R, Leung AY (2007). Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21(7):1423-30.
Crossref |
||||
|
|
||||
|
Christ O, Hamilton M, Smith C, Eaves C (2003). Short and long-term repopulating cells in human cord blood display different levels of aldehyde dehydrogenase activity as revealed by assays of Bodipy-stained cells in NOD/SCID mice. Blood 102:328a.
|
||||
|
|
||||
|
Christ O, Lucke K, Imren S, Leung K, Hamilton M, Eaves A, Smith C, Eaves C (2007). Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity. Haematologica 92(9):1165-72.
Crossref |
||||
|
|
||||
|
Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP (2006). Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 103(31):11707-12.
Crossref |
||||
|
|
||||
|
Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH (1984). Antigenic analysis of hematopoiesis: III, a hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 133(1):157-165
Pubmed |
||||
|
|
||||
|
Colvin O, Thomas E, Blume K, Forman S (1999). Pharmacologic Pur-ging of Bone Marrow. Blackwell Science; Malden, MA. Pp. 202 – 206.
|
||||
|
|
||||
|
Dao M, Arevalo J, Nolta J (2003). Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101:112-118.
Crossref |
||||
|
|
||||
|
David A, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA (2004). Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104(6):1648-1655.
Crossref |
||||
|
|
||||
|
De Wynter E, Buck D, Hart C, et al (1998). CD34+ AC133+ cells isolated from cord blood are highly enriched in long-term culture- initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16: 387-396.
Crossref |
||||
|
|
||||
|
Dorrell C, Gan O, Pereira D, Hawley R, Dick J (2000). Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95:102-110.
Pubmed |
||||
|
|
||||
|
Fallon P, Gentry T, Balber AE, Boulware D, Janssen WE, Smilee R, Storms RW (2003). Mobilized peripheral blood SSClo ALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br. J. Haematol. 122(1):99-108.
Crossref |
||||
|
|
||||
|
Gallacher L, Murdoch B, Wu D, Karanu F, Keeney M, Bhatia M (2000). Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95:2813-2820.
Pubmed |
||||
|
|
||||
|
Gentry T, Foster S, Winstead L, Deibert E, Fiordalisi M, Balber AE (2007). Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implication for cell therapy. Cytotherapy 9(3):259-74.
Crossref |
||||
|
|
||||
|
Schuurhuis GJ, Meel MH, Wouters FW, Min LA, Terwijn M, de Jonge NA, Kelder A, Snel AN, Zweegman S, Ossenkoppele GJ, Smit L (2013). Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells.8(11): e78897.
|
||||
|
|
||||
|
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007). ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Stem Cell 1(5):555–567.
|
||||
|
|
||||
|
Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3(12):1337-1345
Crossref |
||||
|
|
||||
|
Guenechea G, Gan O, Inamitsu T, Dorrell C, Pereira DS, Kelly M, Naldini L, Dick JE (2000). Transduction of human CD34+ CD38-bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol. Ther. 1(16):566-573.
Crossref |
||||
|
|
||||
|
Guenechea G, Gan OI, Dorrell C, Dick J (2001). Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2:75-82.
Crossref |
||||
|
|
||||
|
Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, Kuci S (2003). Biology and plasticity of CD133+ hematopoietic stem cells. Ann. N. Y. Acad. Sci. 996:141-151.
Crossref |
||||
|
|
||||
|
Hess D, Karanu F, Levac K, Gallacher L, Bhatia M (2003). Coculture and transplant of purified CD34(+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells. Leukemia 17:1613-1625.
Crossref |
||||
|
|
||||
|
Hess D, Meyerrose T, Wirthlin L, Craft T, Herrbrich P, Creer M, Nolta J (2004). Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104(6):1648-55.
Crossref |
||||
|
|
||||
|
Hess D, Wirthlin L, Craft T, Herrbrich P, Hohm S, Lahey R, Eades WC, Creer MH, Nolta JA (2006). Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107(5):2162-9.
Crossref |
||||
|
|
||||
|
Hiett A, Britton K, Hague N, Brown H, Stehman F, Broxmeyer H (1995). Comparison of hematopoietic progenitor cells in human umbilical cord blood collected from neonatal infants who are small and appropriate for gestational age. Transfusion 35(7):587-91.
Crossref |
||||
|
|
||||
|
Janssen JJ, Deenik W, Smolders KG, van Kuijk BJ, Pouwels W, Kelder A, Cornelissen JJ, Schuurhuis GJ, Ossenkoppele G (2011). Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib. Leukemia 26(5):977-84.
Crossref |
||||
|
|
||||
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL (2009). Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer. Mol. Cancer Res. 7:330–338.
Crossref |
||||
|
|
||||
|
Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J (1995). Assessment of aldehyde dehydrogenase in viable cells. Blood 85(10):2742-2746.
Pubmed |
||||
|
|
||||
|
Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL (2000). The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14(10):1777–1784.
Crossref |
||||
|
|
||||
|
Juopperi T, Schuler W, Yuan X, Collector M, Dang C, Sharkis S (2007). Isolation of bone marrow-derived stem cells using density-gradient separation. Exp. Hematol. 35(2):335-41.
Crossref |
||||
|
|
||||
|
Morita N, Yamamoto N, Tanizawa T (2003). Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+CD38- human bone marrow cells. Eur. J. Haematol. 71(5):351-8.
Crossref |
||||
|
|
||||
|
Nakamura Y, Ando K, Chargui J, Kawada H, Sato T, Tsuji T, Hotta T, Kato S (1999). Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood 94:4053-4059.
Pubmed |
||||
|
|
||||
|
Pearce DJ, Bonnet D (2007). The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells. Exp. Hematol. 35(9):1437-46.
Crossref |
||||
|
|
||||
|
van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ (2007). Aberrant marker expression patterns on the CD34+CD38– stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia 21(8):1700–1707.
Crossref |
||||
|
|
||||
|
van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G (2007). The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood, 110(7):2659–2666.
Crossref |
||||
|
|
||||
|
Robert W, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C (1999). Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. USA; 96(16):9118–9123.
Crossref |
||||
|
|
||||
|
Sahovic E, Colvin M, Hilton J, Ogawa M (1988). Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro. Cancer Res. 48:1223-1226.
Pubmed |
||||
|
|
||||
|
Sato T, Laver J, Ogawa M (1999). Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94: 2548-2554.
Pubmed |
||||
|
|
||||
|
Sharkis S, Collector M, Barber J, Vala M, Jones R (1997). Phenotypic and functional characterization of the hematopoietic stem cell. Stem Cells 15(suppl 1): 41-45.
Crossref |
||||
|
|
||||
|
Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C (1999). Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad Sci. U S A. 96:9118-9123.
Crossref |
||||
|
|
||||
|
Takebe N, Zhao SC, Adhikari D, Mineishi S, Sadelain M, Hilton J, Colvin M, Banerjee D, Bertino JR (2001). Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Mol. Ther. 3:88-96.
Crossref |
||||
|
|
||||
|
Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S (2009). Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 15:4234–4241.
Crossref |
||||
|
|
||||
|
Terwijn M, Rutten AP, Kelder A, Snel AN, Scholten WJ, et al (2007). Accurate detection of residual leukemic stem cells in remission bone marrow predicts relapse in acute myeloid leukemia patients. Blood ASH Annu Meet: Abstr 759.
|
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
